Adjuvant Systemic Treatment for Renal Cancer After Surgery: A Network Meta-Analysis

Adjuvant Systemic Treatment for Renal Cancer After Surgery: A Network Meta-Analysis

BackgroundApproximately 15% to 20% of patients will experience disease recurrence following surgical removal of renal cell carcinoma. A range of pharmacological agents is prescribed for metastatic renal cell carcinoma, but there are trials testing whether these have an earlier role in the adjuvant s...

Full description

Bibliographic Details
Main Authors: Niranjan J. Sathianathen, Marc A. Furrer, Christopher J. Weight, Declan G. Murphy, Shilpa Gupta, Nathan Lawrentschuk
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Société Internationale d’Urologie Journal
Subjects:
renal cancer
immunotherapy
systematic review
Online Access:https://siuj.org/index.php/siuj/article/view/206/148

Internet

https://siuj.org/index.php/siuj/article/view/206/148

Similar Items